NeuroTherm Buy Boosts St. Jude’s Pain Business

NeuroTherm makes devices for radiofrequency ablation of nerves in painful facet joints in the neck or back to treat chronic pain. Although it markets neurostimulators, St. Jude currently does not sell any devices in the radio-frequency ablation segment of the pain-therapy market.

St. Jude Medical Inc. is expanding its investment in pain therapies by acquiring privately held NeuroTherm Inc., a developer of radiofrequency spinal nerve ablation devices and other minimally invasive devices for treatment of chronic pain.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Archive

More from Medtech Insight